Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02206945 · ClinicalTrials.gov registry record · NA
Neurofeedback for Obsessive-Compulsive Disorder (OCD)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02206945 is a NA study that has completed, run by Yale University. The registered enrollment target is 44 participants.
The verdict
NCT02206945, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The aim of this study is to train patients with obsessive-compulsive disorder to control a region of their brain that has been associated with their symptoms. Patients in the experimental group will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control activity in the region during these feedback sessions. A separate group of patients will be given a control form of feedback that we do not believe can have clinical benefits. Our primary hypothesis is that the neurofeedback training will reduce OCD symptoms more than the control feedback.
Interventions
- BEHAVIORAL neurofeedback
- BEHAVIORAL control feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02206945
The ClinicalTrials.gov registry entry for NCT02206945 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which neurofeedback is the first listed.
NCT02206945 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02206945 about?
NCT02206945 is a clinical study titled "Neurofeedback for Obsessive-Compulsive Disorder (OCD)". The aim of this study is to train patients with obsessive-compulsive disorder to control a region of their brain that has been associated with their symptoms. Patients in the experimental group will be given direct feedback regarding activity in this brain area while they are undergoing functional m...
What is the current status of trial NCT02206945?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-07. Estimated completion is 2021-11.
What interventions are being tested in trial NCT02206945?
The interventions under investigation include: neurofeedback (BEHAVIORAL), control feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02206945?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.